ID   MLTK_HUMAN              Reviewed;         800 AA.
AC   Q9NYL2; B3KPG2; Q53SX1; Q580W8; Q59GY5; Q86YW8; Q9HCC4; Q9HCC5;
AC   Q9HDD2; Q9NYE9;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2005, sequence version 2.
DT   05-OCT-2010, entry version 90.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase MLT;
DE            EC=2.7.11.25;
DE   AltName: Full=Human cervical cancer suppressor gene 4 protein;
DE            Short=HCCS-4;
DE   AltName: Full=Leucine zipper- and sterile alpha motif-containing kinase;
DE   AltName: Full=MLK-like mitogen-activated protein triple kinase;
DE   AltName: Full=Mixed lineage kinase-related kinase;
DE            Short=MLK-related kinase;
DE            Short=MRK;
DE   AltName: Full=Sterile alpha motif- and leucine zipper-containing kinase AZK;
GN   Name=MLTK; Synonyms=ZAK; ORFNames=HCCS4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   AND HOMODIMERIZATION.
RC   TISSUE=Placenta;
RX   MEDLINE=20384179; PubMed=10924358; DOI=10.1006/bbrc.2000.3236;
RA   Liu T.-C., Huang C.-J., Chu Y.-C., Wei C.-C., Chou C.-C., Chou M.-Y.,
RA   Chou C.-K., Yang J.-J.;
RT   "Cloning and expression of ZAK, a mixed lineage kinase-like protein
RT   containing a leucine-zipper and a sterile-alpha motif.";
RL   Biochem. Biophys. Res. Commun. 274:811-816(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, AND
RP   PHOSPHORYLATION.
RC   TISSUE=Fetal brain;
RX   MEDLINE=21264927; PubMed=11042189; DOI=10.1074/jbc.M008595200;
RA   Gotoh I., Adachi M., Nishida E.;
RT   "Identification and characterization of a novel MAP kinase kinase
RT   kinase, MLTK.";
RL   J. Biol. Chem. 276:4276-4286(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Heart;
RX   MEDLINE=21434178; PubMed=11549352; DOI=10.1006/jmcc.2001.1437;
RA   Bloem L.J., Pickard T.R., Acton S., Donoghue M., Beavis R.C.,
RA   Knierman M.D., Wang X.;
RT   "Tissue distribution and functional expression of a cDNA encoding a
RT   novel mixed lineage kinase.";
RL   J. Mol. Cell. Cardiol. 33:1739-1750(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, TISSUE
RP   SPECIFICITY, AND MUTAGENESIS OF LYS-45.
RC   TISSUE=T-cell;
RX   MEDLINE=21950776; PubMed=11836244; DOI=10.1074/jbc.M111994200;
RA   Gross E.A., Callow M.G., Waldbaum L., Thomas S., Ruggieri R.;
RT   "MRK, a mixed lineage kinase-related molecule that plays a role in
RT   gamma-radiation-induced cell cycle arrest.";
RL   J. Biol. Chem. 277:13873-13882(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT SER-531.
RC   TISSUE=Lymphoid tissue;
RA   Abe Y., Ueda N.;
RT   "Placible mixed-lineage kinase derived from LAK cell.";
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RA   Kim J.W.;
RT   "Identification of a new tumor suppressor in human cancers.";
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS SER-531 AND
RP   THR-784.
RA   McNee J.J., Frima N., Diamond T.E., Dower S.K., Guesdon F.;
RT   "Cloning and characterisation of AZK, a mixed lineage kinase
RT   containing a sterile-alpha motif.";
RL   Submitted (APR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   SER-531.
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   INTERACTION WITH ZNF33A.
RX   MEDLINE=22422561; PubMed=12535642; DOI=10.1016/S0006-291X(02)02980-7;
RA   Yang J.-J.;
RT   "A novel zinc finger protein, ZZaPK, interacts with ZAK and stimulates
RT   the ZAK-expressing cells re-entering the cell cycle.";
RL   Biochem. Biophys. Res. Commun. 301:71-77(2003).
RN   [14]
RP   PHOSPHORYLATION, AND INTERACTION WITH PKN1.
RX   MEDLINE=22646196; PubMed=12761180; DOI=10.1093/jb/mvg022;
RA   Takahashi M., Gotoh Y., Isagawa T., Nishimura T., Goyama E.,
RA   Kim H.-S., Mukai H., Ono Y.;
RT   "Regulation of a mitogen-activated protein kinase kinase kinase, MLTK
RT   by PKN.";
RL   J. Biochem. 133:181-187(2003).
RN   [15]
RP   FUNCTION.
RX   PubMed=15172994; DOI=10.1158/0008-5472.CAN-04-0201;
RA   Cho Y.-Y., Bode A.M., Mizuno H., Choi B.Y., Choi H.S., Dong Z.;
RT   "A novel role for mixed-lineage kinase-like mitogen-activated protein
RT   triple kinase alpha in neoplastic cell transformation and tumor
RT   development.";
RL   Cancer Res. 64:3855-3864(2004).
RN   [16]
RP   FUNCTION, ENZYME REGULATION, PHOSPHORYLATION AT THR-161 AND SER-165,
RP   AND MUTAGENESIS OF THR-161; THR-162 AND SER-165.
RX   PubMed=15342622; DOI=10.1074/jbc.M409961200;
RA   Tosti E., Waldbaum L., Warshaw G., Gross E.A., Ruggieri R.;
RT   "The stress kinase MRK contributes to regulation of DNA damage
RT   checkpoints through a p38gamma-independent pathway.";
RL   J. Biol. Chem. 279:47652-47660(2004).
RN   [17]
RP   FUNCTION IN PHOSPHORYLATION OF HISTONE H3, AND SUBCELLULAR LOCATION.
RX   PubMed=15684425; DOI=10.1074/jbc.M410521200;
RA   Choi H.S., Choi B.Y., Cho Y.-Y., Zhu F., Bode A.M., Dong Z.;
RT   "Phosphorylation of Ser28 in histone H3 mediated by mixed lineage
RT   kinase-like mitogen-activated protein triple kinase alpha.";
RL   J. Biol. Chem. 280:13545-13553(2005).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-637, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-637, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-633 AND SER-637, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18187866; DOI=10.2116/analsci.24.161;
RA   Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
RT   "Automated phosphoproteome analysis for cultured cancer cells by two-
RT   dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
RL   Anal. Sci. 24:161-166(2008).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-591; SER-593 AND
RP   SER-599, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; SER-268; SER-275;
RP   SER-302; THR-328; SER-593; THR-628; SER-633; SER-637; SER-687;
RP   SER-691; SER-727; SER-733 AND SER-781, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-339; SER-434 AND SER-454 (ISOFORM 2), AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-599; THR-628; SER-633;
RP   SER-727 AND SER-733, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-434
RP   AND SER-454 (ISOFORM 2), AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-636 AND SER-637, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-3; SER-155;
RP   SER-264; SER-275; SER-302; SER-326; THR-328; TRP-339; GLU-429;
RP   LYS-434; ASP-454; SER-557; SER-565; SER-568; SER-584; THR-586;
RP   SER-591; SER-593; THR-628; SER-633; SER-635; SER-637; THR-639;
RP   SER-648; SER-660; THR-666; SER-667; SER-668; SER-687; SER-690;
RP   SER-691; SER-718; SER-727; SER-733 AND SER-754, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-339; SER-429; SER-434 AND SER-454 (ISOFORM 2),
RP   AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-633, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [27]
RP   VARIANTS [LARGE SCALE ANALYSIS] MET-267; THR-281; VAL-281; SER-531;
RP   TRP-580; THR-740; HIS-773 AND THR-784.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Stress-activated component of a protein kinase signal
CC       transduction cascade. Regulates the JNK and p38 pathways. Pro-
CC       apoptotic. Role in regulation of S and G2 cell cycle checkpoint by
CC       direct phosphorylation of CHEK2. Isoform 1, but not isoform 2,
CC       causes cell shrinkage and disruption of actin stress fibers.
CC       Isoform 1 may have role in neoplastic cell transformation and
CC       cancer development. Isoform 1, but not isoform 2, phosphorylates
CC       histone H3 at 'Ser-28'.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Activated by phosphorylation by PKN1 and
CC       autophosphorylation on Thr-161 and Ser-165.
CC   -!- SUBUNIT: Homodimer. Interacts with PKN1 and ZNF33A.
CC   -!- INTERACTION:
CC       Self; NbExp=1; IntAct=EBI-602273, EBI-602273;
CC       Q16512:PKN1; NbExp=1; IntAct=EBI-602273, EBI-602382;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Translocates to the
CC       nucleus upon ultraviolet B irradiation.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Alpha;
CC         IsoId=Q9NYL2-1; Sequence=Displayed;
CC       Name=2; Synonyms=Beta;
CC         IsoId=Q9NYL2-2; Sequence=VSP_051743, VSP_051744;
CC         Note=Phosphorylated on Ser-339, Ser-429, Ser-434 and Ser-454;
CC       Name=3; Synonyms=HCCS-4;
CC         IsoId=Q9NYL2-3; Sequence=VSP_051741, VSP_051742;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Isoform 2 is the
CC       predominant form in all tissues examined, except for liver, in
CC       which isoform 1 is more highly expressed.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase kinase subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 SAM (sterile alpha motif) domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92211.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF238255; AAF63490.1; -; mRNA.
DR   EMBL; AB049733; BAB16444.1; -; mRNA.
DR   EMBL; AB049734; BAB16445.1; -; mRNA.
DR   EMBL; AF325454; AAK11615.1; -; mRNA.
DR   EMBL; AF480461; AAL85891.1; -; mRNA.
DR   EMBL; AF480462; AAL85892.1; -; mRNA.
DR   EMBL; AB030034; BAB12040.1; -; mRNA.
DR   EMBL; AF465843; AAO33376.1; -; mRNA.
DR   EMBL; AF251441; AAF65822.1; -; mRNA.
DR   EMBL; AK056310; BAG51674.1; -; mRNA.
DR   EMBL; AB208974; BAD92211.1; ALT_INIT; mRNA.
DR   EMBL; AC092573; AAX82002.1; -; Genomic_DNA.
DR   EMBL; AC013461; AAX93067.1; -; Genomic_DNA.
DR   EMBL; AC019046; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471058; EAX11164.1; -; Genomic_DNA.
DR   EMBL; BC001401; AAH01401.1; -; mRNA.
DR   IPI; IPI00029643; -.
DR   IPI; IPI00329638; -.
DR   IPI; IPI00384771; -.
DR   RefSeq; NP_057737.2; -.
DR   RefSeq; NP_598407.1; -.
DR   UniGene; Hs.444451; -.
DR   ProteinModelPortal; Q9NYL2; -.
DR   SMR; Q9NYL2; 8-264, 326-408.
DR   IntAct; Q9NYL2; 11.
DR   MINT; MINT-1465549; -.
DR   STRING; Q9NYL2; -.
DR   PhosphoSite; Q9NYL2; -.
DR   PRIDE; Q9NYL2; -.
DR   Ensembl; ENST00000375213; ENSP00000364361; ENSG00000091436.
DR   GeneID; 51776; -.
DR   KEGG; hsa:51776; -.
DR   UCSC; uc002uhx.2; human.
DR   UCSC; uc002uhy.1; human.
DR   UCSC; uc002uhz.1; human.
DR   CTD; 51776; -.
DR   GeneCards; GC02P173904; -.
DR   H-InvDB; HIX0002600; -.
DR   HPA; HPA017205; -.
DR   MIM; 609479; gene.
DR   eggNOG; prNOG07088; -.
DR   HOVERGEN; HBG080445; -.
DR   OMA; ETMANDS; -.
DR   BRENDA; 2.7.11.25; 247.
DR   Pathway_Interaction_DB; p38gammadeltapathway; Signaling mediated by p38-gamma and p38-delta.
DR   NextBio; 55903; -.
DR   ArrayExpress; Q9NYL2; -.
DR   Bgee; Q9NYL2; -.
DR   Genevestigator; Q9NYL2; -.
DR   GermOnline; ENSG00000091436; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0004709; F:MAP kinase kinase kinase activity; IDA:UniProtKB.
DR   GO; GO:0007257; P:activation of JUN kinase activity; IDA:UniProtKB.
DR   GO; GO:0000186; P:activation of MAPKK activity; TAS:UniProtKB.
DR   GO; GO:0007050; P:cell cycle arrest; IMP:UniProtKB.
DR   GO; GO:0008219; P:cell death; NAS:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; NAS:UniProtKB.
DR   GO; GO:0008283; P:cell proliferation; NAS:UniProtKB.
DR   GO; GO:0000077; P:DNA damage checkpoint; IMP:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptosis; IDA:UniProtKB.
DR   GO; GO:0009314; P:response to radiation; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM_type.
DR   InterPro; IPR021129; SAM_type1.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR010993; Sterile_alpha_motif_homology.
DR   Gene3D; G3DSA:1.10.150.50; SAM_type; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00536; SAM_1; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00454; SAM; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF47769; SAM_homology; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell cycle; Complete proteome;
KW   Cytoplasm; Kinase; Magnesium; Metal-binding; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Polymorphism; Proto-oncogene;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    800       Mitogen-activated protein kinase kinase
FT                                kinase MLT.
FT                                /FTId=PRO_0000086338.
FT   DOMAIN       16    277       Protein kinase.
FT   DOMAIN      287    308       Leucine-zipper.
FT   DOMAIN      339    410       SAM.
FT   NP_BIND      22     30       ATP (By similarity).
FT   ACT_SITE    133    133       Proton acceptor (By similarity).
FT   BINDING      45     45       ATP.
FT   MOD_RES       2      2       Phosphoserine.
FT   MOD_RES       3      3       Phosphoserine.
FT   MOD_RES     155    155       Phosphoserine.
FT   MOD_RES     161    161       Phosphothreonine; by autocatalysis.
FT   MOD_RES     165    165       Phosphoserine; by autocatalysis.
FT   MOD_RES     264    264       Phosphoserine.
FT   MOD_RES     268    268       Phosphoserine.
FT   MOD_RES     275    275       Phosphoserine.
FT   MOD_RES     302    302       Phosphoserine.
FT   MOD_RES     326    326       Phosphoserine.
FT   MOD_RES     328    328       Phosphothreonine.
FT   MOD_RES     557    557       Phosphoserine.
FT   MOD_RES     565    565       Phosphoserine.
FT   MOD_RES     568    568       Phosphoserine.
FT   MOD_RES     584    584       Phosphoserine.
FT   MOD_RES     586    586       Phosphothreonine.
FT   MOD_RES     591    591       Phosphoserine.
FT   MOD_RES     593    593       Phosphoserine.
FT   MOD_RES     599    599       Phosphoserine.
FT   MOD_RES     628    628       Phosphothreonine.
FT   MOD_RES     633    633       Phosphoserine.
FT   MOD_RES     635    635       Phosphoserine.
FT   MOD_RES     636    636       Phosphoserine.
FT   MOD_RES     637    637       Phosphoserine.
FT   MOD_RES     639    639       Phosphothreonine.
FT   MOD_RES     648    648       Phosphoserine.
FT   MOD_RES     660    660       Phosphoserine.
FT   MOD_RES     666    666       Phosphothreonine.
FT   MOD_RES     667    667       Phosphoserine.
FT   MOD_RES     668    668       Phosphoserine.
FT   MOD_RES     687    687       Phosphoserine.
FT   MOD_RES     690    690       Phosphoserine.
FT   MOD_RES     691    691       Phosphoserine.
FT   MOD_RES     718    718       Phosphoserine.
FT   MOD_RES     727    727       Phosphoserine.
FT   MOD_RES     733    733       Phosphoserine.
FT   MOD_RES     754    754       Phosphoserine.
FT   MOD_RES     781    781       Phosphoserine.
FT   VAR_SEQ     285    312       CEIEATLERLKKLERDLSFKEQELKERE -> WVAPTAGHS
FT                                VWLSKTITRLNEEVNQRSE (in isoform 3).
FT                                /FTId=VSP_051741.
FT   VAR_SEQ     313    800       Missing (in isoform 3).
FT                                /FTId=VSP_051742.
FT   VAR_SEQ     332    455       PSFEIGAWTEDDVYCWVQQLVRKGDSSAEMSVYASLFKENN
FT                                ITGKRLLLLEEEDLKDMGIVSKGHIIHFKSAIEKLTHDYIN
FT                                LFHFPPLIKDSGGEPEENEEKIVNLELVFGFHLKPGTGPQD
FT                                C -> LPLAARMSEESYFESKTEESNSAEMSCQITATSNGE
FT                                GHGMNPSLQAMMLMGFGDIFSMNKAGAVMHSGMQINMQAKQ
FT                                NSSKTTSKRRGKKVNMALGFSDFDLSEGDDDDDDDGEEEDN
FT                                DMDNSE (in isoform 2).
FT                                /FTId=VSP_051743.
FT   VAR_SEQ     456    800       Missing (in isoform 2).
FT                                /FTId=VSP_051744.
FT   VARIANT     267    267       T -> M (in dbSNP:rs6758025).
FT                                /FTId=VAR_040806.
FT   VARIANT     281    281       A -> T (in an ovarian endometrioid
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040807.
FT   VARIANT     281    281       A -> V (in dbSNP:rs34683477).
FT                                /FTId=VAR_040808.
FT   VARIANT     531    531       L -> S (in dbSNP:rs3769148).
FT                                /FTId=VAR_022827.
FT   VARIANT     580    580       R -> W (in dbSNP:rs7593622).
FT                                /FTId=VAR_040809.
FT   VARIANT     740    740       P -> T (in dbSNP:rs56202258).
FT                                /FTId=VAR_040810.
FT   VARIANT     773    773       Y -> H (in dbSNP:rs35608243).
FT                                /FTId=VAR_040811.
FT   VARIANT     784    784       K -> T (in dbSNP:rs55830025).
FT                                /FTId=VAR_040812.
FT   MUTAGEN      45     45       K->M: Loss of kinase activity.
FT   MUTAGEN     161    161       T->A: Loss of autophosphorylation
FT                                activity.
FT   MUTAGEN     162    162       T->A: Slight loss of autophosphorylation
FT                                activity.
FT   MUTAGEN     165    165       S->A: Loss of autophosphorylation
FT                                activity.
FT   CONFLICT    346    346       C -> W (in Ref. 1; AAF63490).
SQ   SEQUENCE   800 AA;  91181 MW;  B289D836EC52E295 CRC64;
     MSSLGASFVQ IKFDDLQFFE NCGGGSFGSV YRAKWISQDK EVAVKKLLKI EKEAEILSVL
     SHRNIIQFYG VILEPPNYGI VTEYASLGSL YDYINSNRSE EMDMDHIMTW ATDVAKGMHY
     LHMEAPVKVI HRDLKSRNVV IAADGVLKIC DFGASRFHNH TTHMSLVGTF PWMAPEVIQS
     LPVSETCDTY SYGVVLWEML TREVPFKGLE GLQVAWLVVE KNERLTIPSS CPRSFAELLH
     QCWEADAKKR PSFKQIISIL ESMSNDTSLP DKCNSFLHNK AEWRCEIEAT LERLKKLERD
     LSFKEQELKE RERRLKMWEQ KLTEQSNTPL LPSFEIGAWT EDDVYCWVQQ LVRKGDSSAE
     MSVYASLFKE NNITGKRLLL LEEEDLKDMG IVSKGHIIHF KSAIEKLTHD YINLFHFPPL
     IKDSGGEPEE NEEKIVNLEL VFGFHLKPGT GPQDCKWKMY MEMDGDEIAI TYIKDVTFNT
     NLPDAEILKM TKPPFVMEKW IVGIAKSQTV ECTVTYESDV RTPKSTKHVH LIQWSRTKPQ
     DEVKAVQLAI QTLFTNSDGN PGSRSDSSAD CQWLDTLRMR QIASNTSLQR SQSNPILGSP
     FFSHFDGQDS YAAAVRRPQV PIKYQQITPV NQSRSSSPTQ YGLTKNFSSL HLNSRDSGFS
     SGNTDTSSER GRYSDRSRNK YGRGSISLNS SPRGRYSGKS QHSTPSRGRY PGKFYRVSQS
     ALNPHQSPDF KRSPRDLHQP NTIPGMPLHP ETDSRASEED SKVSEGGWTK VEYRKKPHRP
     SPAKTNKERA RGDHRGWRNF
//
